Background: Topical calcineurin inhibitors are licensed for the treatment of atopic dermatitis; however, the efficacy of tacrolimus in cutaneous lupus erythematosus (CLE) has only been shown in single case reports.
Objective: In a multicenter, randomized, double-blind, vehicle-controlled trial, we sought to evaluate the efficacy of tacrolimus 0.1% ointment for skin lesions in CLE.
Objective: We sought to assess if the exclusive use of a broad-spectrum sunscreen can prevent skin lesions in patients with different subtypes of cutaneous lupus erythematosus (CLE) induced by ultraviolet (UV) irradiation under standardized conditions.
Methods: A total of 25 patients with a medical history of photosensitive CLE were included in this monocentric, randomized, vehicle-controlled, double-blind, intraindividual study. The test product and its vehicle were applied 15 minutes before UVA and UVB irradiation of uninvolved skin areas on the upper aspect of the back in a random order, and standardized phototesting was performed daily for 3 consecutive days.
Objectives: To assess the effect of the ET-receptor antagonist bosentan on skin fibrosis and functionality in patients with SSc.
Methods: In this prospective, open-label, non-comparative trial, a total of 10 patients with SSc received 62.5 mg of bosentan twice daily for 4 weeks and then 125 mg twice daily for 20 weeks.
Objective: This study was undertaken following a request of the Bavarian Ministry of Sciences, Research and the Arts to analyse the future provision in different occupational areas.
Methods: In a preliminary enquiry, statistics of the Medical Association of Bavaria (BLAEK) were analysed for several years (2000-2004) to find out how many physicians are working in different occupational areas and fields, according to gender. In early 2004 a questionnaire was sent to all physicians who had received their licences to practise medicine in the four preceding years and were still reported to the Medical Association of Bavaria.
Acute generalized exanthematous pustulosis (AGEP) is characterized by an acute disseminated eruption of multiple, non-follicular pustules. In addition, it can be associated with fever, elevated erythrocyte sedimentation rate, and leukocytosis. The pathogenesis of AGEP is still unknown; however, medications appear a likely cause in most cases.
View Article and Find Full Text PDF